chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Expired vaccine administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered). On 04-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  The vial was removed from the freezer today 04-Jan-2022. HCP thought that the vaccine was supposed to be good for 6 months. After vaccination, she scanned the vial to write the expiration date on the vaccination card and noticed that the vaccine expired 11 days ago on 23-DEC-2021.  Treatment information was not provided.
Received DTaP #4 (2/4/02). 2/6/02 Large swollen area around the immunization site with erythema. that spread to face, back, arms and left leg, not itching. Will be treated with Benadryl.
After receiving the first dose of Moderna, the patient reacted 7 mins later with hives, Benadryl was given on site and the hives subsided hours later without worsening of symptoms. Prior to receiving her second dose, the patient checked with her PCP and was told she can receive the second dose, but to eventually follow up with an allergist (although this does not have to be prior to receiving their second dose). Benadryl 50 mg was given prior to second dose Moderna was given with good effect.
No adverse symptoms reported; Some of the varivax squirted onto her forehead and left cheek; Some of the varivax squirted onto her forehead and left cheek; This spontaneous report was received from a 55-year-old female patient (nurse) reporting on herself. The patient's pertinent medical history, drug reactions/allergies and concomitant medications were reported as none. On 14-MAY-2020, while drawing a reconstituted varicella virus vaccine live (Oka/Merck) (VARIVAX) (strength, dose, frequency, schedule and route were not reported) (lot# S015465 expiration date reported as 20-MAY-2021), the needle popped off of the end of the syringe and some of the vaccine squirted onto her forehead and left cheek (occupational exposure to product and accidental exposure to product). Other suspect therapy included sterile diluent which was used for reconstitution of the vaccine (lot# S033782 expiration date reported as 18-JUN-2022). It was reported that, she cleaned the area with soap and water. No adverse symptoms reported. The exposure was happened at the office and it was handled right away without any treatment.
No additional AE details are available; 9 month old was administered with dose of ROTATEQ; This spontaneous report was received from an office manager and refers to a 9-month-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not provided.  On 07-MAR-2022 (also reported as today), the patient was vaccinated with 1 dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot #1742431, expiration date: 31-JAN-2023 (dose not provided), administered orally for prophylaxis (product administered to patient of inappropriate age). No additional adverse event details were available (no adverse event).
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated inadvertently with 2 doses of (Oka/Merck) VARIVAX (lot#, doses not provided) during the same office visit. No adverse effects reported. Additional information is not expected, because the call was abruptly discontinued before any demographic information could be obtained.
27OCT window fell on lt index finger Tetanus vax given;29OCT rt upper arm edematous & pt c/o chills;MD prescribed warm compresses, motrin & hydrocortisone cream over the site;5NOV pt seen again by MD problem resolved;
hard to eat; hard to talk; excruciating headache which she had to get an icepack, but it still hurts; fever; chills; This is a spontaneous report from a contactable consumer (patient). This female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date: Unknown), via an unspecified route of administration on an unspecified date in 2021 as dose 2, single for covid-19 immunisation. Medical history included ongoing lung disease. The patient's concomitant medications were not reported. Previously, the patient had first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date: Unknown), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation and didn't have any reaction at first and noticed after 3 day she had difficulty of breathing and 4 days after it got worse. She had the second dose in 2021 (Saturday) and in 2021 experienced fever, chills, and excruciating headache which she had to get an icepack, but it still hurt. She did have lung disease but had never experienced that. On 30Aug2021 (today), it was hard for her to talk and it was hard to eat. She said that she did not have COVID symptoms. She also mentioned that the hospitals were full of COVID patients and they could not help her. She had oxygen on her house. She wanted to let Pfizer know that she had these side effects and wanted to know if anybody had reported these. Therapeutic measures were taken as a result of excruciating headache. The outcome of all events was unknown.  Follow-up attempts have been completed and no further information is expected.
2 inch bruise and (5) papular bumps over the injection site with soreness at injection site and bruised area.  Starting to fade after 12 days with some tenderness.
Information has been received from a physician concerning a female with a history of guttate psoriasis who was vaccinated with a "single dose" of ZOSTAVAX.  On an unspecified date, about a couple of days post vaccination, the patient broke out with a case of "guttate psoriasis".  The physician reported that the patient has not had an outbreak in about 20 years, but the day of receiving ZOSTAVAX the patient may have had an upper respiratory infection.  The patient sought medical attention via her physician.  At the time of the report the patient's status was unknown.  A product quality complaint was not involved.  No further information is available.
Suspected vaccination failure; Got shingles; High level of stress; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included stress (4 years ago the patient had stressful situation ), difficulty in standing (the patient couldn't stand to wear pants for 6 weeks) and pain. Previously administered products included Shingles vaccine with an associated reaction of herpes zoster (received single dose of shingles vaccine 8 years ago and experienced shingles).   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and stress. On an unknown date, the outcome of the vaccination failure, shingles and stress were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and stress to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient stated that 8 years ago the patient had the single vaccine. 4 years ago after a stressful situation the patient came down with shingles around waist and on upper hips. The patient could not stand to wear pants for 6 weeks and could barely stand loose underwear. When the patient recovered the doctor gave a prescription for the 2 shots about 2 months apart. The one shot vaccine was not as effective. The patient got shingles 3 years after taking shingles vaccine. They were so painful.  The patient had received two shingles shots and still experienced shingles. The physician said high level of stress caused flare up. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles were not provided.
This spontaneous report as received from a medical assistant via a company representative refers to a 11-12 year old male patient. On an unknown date the patient was vaccinated with GARDASIL (lot # not reported) (dose 1, intramuscular, dose as indicated, strength and total daily dose not reported). Concomitant therapies included MENACTRA and TDAP. The patient experienced syncope after receiving the first dose of GARDASIL. The patient fainted in office during the visit and sought for unspecified medical attention by being attended to office. No treatment was given. The patient recovered in office. This is one of several reports received from the same source. Additional information is not expected.
No adverse event; Dose administered after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M21A) for COVID-19 prophylaxis.     It was unknown if patient had allergies to medication, foods and other products. It was unknown if patient had ever been diagnosed with and or tested positive with COVID-19. Acute illness at the time of vaccination and up to one month before was unknown. On 20-Sep-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry).    No concomitant medications were reported.  Expired Moderna vaccine was given to the patient. The vial was taken out of the freezer recently. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergo temperature excursion. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow up received, updated reporter details.
02/27/2021 After vaccination that evening, I started having a low grade fever; felt horrible. I was achy, my teeth hurt.  02/28/2021 Took Tylenol. Huge pain at injection site; 7/10. Over the next 2-3 days, those symptoms got better but I started to notice I would get tired. I am a Kindergarten teacher, it was getting harder to keep going. At one point, I couldn't get up / weakness in my legs. *Muscular Dystrophy *non treatable disease that gets worse over time. **COVID
Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 02-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided by the reporter No treatment information provided. The vaccine was initially stored in refrigerator on 16-Sep-2021.   This case was linked to MOD-2021-391855 (Patient Link).
This spontaneous report was received from a physician referring to a patient of unknown age and gender who on 07-APR-2014, was vaccinated with an expired dose of ROTATEQ (lot # H016259, expiration date 26-MAR-2014), 2 ml, oral. No adverse effects were reported. Additional information has been requested.
balance problem; loss sense of smell; loss sense of taste; severe headache/head hurting really bad; Low grade fever; The patient tested positive for Covid19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (The patient tested positive for Covid19), BALANCE DISORDER (balance problem), ANOSMIA (loss sense of smell), AGEUSIA (loss sense of taste) and HEADACHE (severe headache/head hurting really bad) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Malaria. Concurrent medical conditions included Blood pressure, Cholesterol and Dementia.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced COVID-19 (The patient tested positive for Covid19). On an unknown date, the patient experienced BALANCE DISORDER (balance problem), ANOSMIA (loss sense of smell), AGEUSIA (loss sense of taste), HEADACHE (severe headache/head hurting really bad) and PYREXIA (Low grade fever). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. At the time of the report, COVID-19 (The patient tested positive for Covid19), BALANCE DISORDER (balance problem), ANOSMIA (loss sense of smell), AGEUSIA (loss sense of taste), HEADACHE (severe headache/head hurting really bad) and PYREXIA (Low grade fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, SARS-CoV-1 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was mentioned as patient is taking blood pressure medication, cholesterol medication and dementia medication. Treatment medication was mentioned as patient was treated with an infusion, antibiotic, cough medicine, and a medicine which patient took for malaria which is taken 5 times a day.
Nerve pain in right abdominal quadrant similar to pain experienced when she was diagnose with shingles in May 2014. Treatment: Acyclovir 400 mg 2 tabs five times daily x 7 days, NEURONTIN 100 mg twice daily as needed for pain.
Redness, swelling area 9x9 warm to touch noted 24-30 hrs after injection.  Treated with Tylenol/children and application of ice to site.
1 1/4 hrs. after immunization - pt. became dyspneic, went to nearby clinic - was given epinephrine and O2. Returned to home in satisfactory condition.
On 8-9-2010 client was given H1N1 0.1ml. intradermally instead of TB - PPD in the left inner forearm. 8-11-2010 observed area at site to be 1 cm x 2 cm of redness. States more irritation yesterday. Had taken BENADRYL.
mom states redness started same noc of vax seen in MD office 6NOV97 MD comment allerg rxn, wheal mom notified on  7NOV arm much better not as red or as big 10NOV;better & color faint;
Patient presented to ED on 04/18/2021 with cardiopulmonary arrest, per ED "He was receiving CPR with EMS for arrival to the emergency.  Two rounds epi.  Asystole and then went into V-tach.  Got shocked once.  Then after that has been strip PA asystole." ED called time of death on patient 04/18/2021 at  05:14AM.
small redness the first day and soreness then on day #9 developed itching and swelling - warm to touch
notice pain in left ring finger/By 6pm very painful; loss of range of motion; ring finger swollen; This is a spontaneous report from a contactable nurse. A 24-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 19Jan2021 10:30 at a single dose for covid-19 immunization. Medical history included allergy to penicillin and gluten intolerance. Concomitant medication included ethinylestradiol, norgestimate (TRI-PREVIFEM). Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 31Dec2020 (first dose). It was reported that the patient received the vaccine in left arm, a few hours later began to notice pain in left ring finger. By 6pm very painful and loss of range of motion, ring finger swollen; all on 19Jan2021 13:30. No treatment was received for the events. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Child had a near syncopal episode 20 minutes after vaccination, evaluated by pediatrician, juice provided. Child felt better and went home from Covid Vaccine clinic
Information has been received from a registered nurse concerning a 58 year old female with breast cancer, diabetes, hypertension, hernia, stomach polyps and AUGMENTIN allergy who on 24-OCT-2006 was vaccinated with Pneumovax 23 (lot # 651404/0352F) (0.5 ml), intramuscularly.  Concomitant therapy included losartan potassium (MSD), LYRICA, ZELNORM, ACTOS, ARIMIDEX, and "ZELGRID".  On 25-OCT-2006 the patient experienced fever of 101.3 F, swelling and pain at the injection site.  The physician recommended TYLENOL and ice compresses.  A lot check was requested.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot met the requirements of the agency and was released.  Additional information has been requested.
Extremely itchy palms and soles of feet; and various itching all over the body that began on 1/11/2022 or 1/12/2022 and continuing.
swollen fingers and feet; Felt in chest like she had been beaten or hit herself heavily; chest area was sore; Sensation like she had applied vapor rub in the inside; allergic reaction; it was irritated right in the center from throat down lower; circle of warmth in the chest; This is a spontaneous report from a non-contactable consumer (patient herself). A 67-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot Number: EN6205), via an unspecified route of administration, administered in Arm Left (upper part) on 05Mar2021 09:30 (age at vaccination: 67 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were none. The patient did not receive any vaccinations prior to four weeks. On an unknown date, the patient experienced swollen fingers and feet on the third day and then it cleared, it was not drastic just a lit bit of swelling; felt in chest like she had been beaten or hit herself heavily, chest area was sore, sensation like she had applied vapor rub in the inside also referred to sensation as if she applied hot pepper, it was irritated right in the center from throat down lower. Caller stated this started after she first noticed the warmth. Caller stated it came on gradually; she stated what remains in the tiny spot in the stomach between chest in the solar plexus. It was just a tiny spot. Reporter clarified that this was at the end of the bone which is what she thinks is called the hypothesis just under the bone in the center in that area. She recovered but has occasional sensation, felt it could have been an irritation of the lining or tissues and that she does not know but it is pretty much cleared by this morning. She clarified that the little tiny spot that still remains warmth is just the remnants that she experience down the entire tube and only that spot in the bottom of the tube. She felt much more back to normal. On 12Mar2021, 8 days after the shot, the patient experienced circle of warmth in the chest. She is still only experiencing a little tiny bit in the pleural sac area not but it is much less, it seemed to stay the same for a while and gradually started to get better and felt better two weeks after she received the shot. She was back to normal. The patient believes is an allergic reaction. The patient did not receive any treatment for the adverse events. The patient did not visit physician's or emergency room. The outcome of peripheral swelling, chest discomfort, chest pain was recovered on an unknown date in 2021; feeling hot, feeling abnormal, throat irritation was recovering; hypersensitivity was unknown.  No follow-up attempts are possible. No further information is expected.
5/7/99 pt complains of testicle pain coming and going and occasional rashes on chest
11PM 2/24/2021 - 4PM 2/25/2021 Alternating chills and low-grade fever (99.6-100) Migraine Upper back pain Arm soreness
Recieved influenza vaccination on 11/2/07 and felt immediate pain at injection site which proceded down arm into 4th and 5th fingers.  Pain has persisted since 11/2/07.
Right arm pain same day - elbow - shoulder - neck - top of arm - 24 hour pain (no let up). Fever, loss of appetite, slept when I could. No energy. Developed runny sinus. Head and chest cold and have lost my voice. Neither heat nor cold helped.
Fever up to 104, lasting 4 hours. Chills. Malaise. Severe pain at the injection site lasting several weeks.
Patient stated that her throat felt tight and was holding her throat. Epinephrine 0.3 mg administered IM  and diphenhydramine 10 ml administered by mouth.  Patient went to the ER and they gave her an additional dosage of epinephrine and she recovered and went home.
Wild weird dreams; Many every night also very tired; Brain fog; Forgetfull; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 22Apr2021 at 16:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported and the patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of the vaccination. On 22Apr2021 at 22:30, the patient experienced wild weird dreams, many every night also very tired and brain fog and forgetful. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events wild weird dreams, many every night also very tired, and brain fog and forgetful was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Have episodes where I cannot hold urine. After talking with friends who are experiencing the same thing we only have the Covid Vaccine in common. Only happens occasionally.